The first quarter of 2024 has concluded, leaving a landscape reshaped by evolving market dynamics, groundbreaking therapeutic advancements, and persistent…
Read More
OpenBench and Concept Life Sciences Forge Strategic Alliance to Revolutionize Early-Stage Drug Discovery with Fee-for-Success Model
A groundbreaking strategic partnership has been announced between OpenBench, a pioneer in AI-driven drug discovery, and Concept Life Sciences, a…
Read More
Gilead Sciences Finalizes $5 Billion Acquisition of Tubulis, Bolstering Oncology Pipeline with Advanced ADC Technology
Gilead Sciences has officially completed its acquisition of Tubulis, a prominent German biotechnology firm specializing in the development of next-generation…
Read More
Europe Faces a Decade-High Surge in Sexually Transmitted Infections, Highlighting Urgent Need for Enhanced Prevention and Treatment Strategies
New data released by Europe’s leading infectious disease agency reveals a concerning decade-high surge in bacterial sexually transmitted infections (STIs),…
Read More
Paradigm Health Launches SPIRE Platform to Revolutionize Post-Approval Oncology Research
The landscape of oncology therapeutics is rapidly evolving, with groundbreaking treatments continuously emerging and receiving regulatory approval. However, the journey…
Read More
CVC Capital Partners and Groupe Bruxelles Lambert Launch $12.4 Billion Takeover Bid for Recordati, Signaling Potential Shift to Private Ownership
One of Italy’s few remaining publicly traded large pharmaceutical companies, Recordati, is on the cusp of transitioning to private ownership…
Read More
Q&A: How 3PLs are navigating the latest pharma trends – Pharmaceutical Technology
The pharmaceutical logistics landscape is undergoing a profound transformation, moving beyond the traditional "store and ship" model to embrace comprehensive…
Read More
FUJIFILM Cellular Dynamics Inaugurates State-of-the-Art Induced Pluripotent Stem Cell Manufacturing Facility in Madison, Wisconsin
FUJIFILM Cellular Dynamics has officially opened its new headquarters and a cutting-edge induced pluripotent stem cell (iPSC) manufacturing facility in…
Read More
Gilead Sciences Pledges Over 400,000 Doses of AmBisome to Combat Visceral Leishmaniasis, Extending Vital Global Health Partnership
Gilead Sciences has announced a significant commitment to global health, pledging over 400,000 doses of its vital antifungal medication, AmBisome…
Read More
Eli Lilly Acquires Engage Biologics for Up to $202 Million, Bolstering Its Genetic Medicine Pipeline with Innovative Non-Viral DNA Delivery Technology
Pharmaceutical giant Eli Lilly and Company has announced its agreement to acquire Engage Biologics, a California-based biotechnology firm, for a…
Read MoreYOU MAY HAVE MISSED
